You're viewing a public preview of Hemax Genome, Inc. Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Hemax Genome, Inc.

Inactive
5415 Boulevard de l'Assomption,  Quebec,  Canada
Sector: Life Science Entity: Private
Acquired Hemax Genome, Inc. acquired by Emerillon Therapeutics, Inc. in 2005
1
Transactions
Sign up to view
About Hemax Genome, Inc.
Hemax Genome, Inc. is a privately held company operates in the Life Science sector. Investment activity recorded for the company includes participation from Emerillon Therapeutics, Inc.. The company is headquartered in Quebec.
Investors
Current Investors
Emerillon Therapeutics, Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
1 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 1 Transaction
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Hemax Genome, Inc. M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Hemax Genome, Inc. do?
Hemax Genome, Inc. is a privately held company operates in the Life Science sector. Investment activity recorded for the company includes participation from Emerillon Therapeutics, Inc.. The company is headquartered in Quebec.
Where is Hemax Genome, Inc. headquartered?
Hemax Genome, Inc. is headquartered in Quebec, Canada.
When was Hemax Genome, Inc. founded?
Founded year information for Hemax Genome, Inc. is available on AcquityData.
What sector is Hemax Genome, Inc. in?
Hemax Genome, Inc. operates in the Life Science sector.
Who are the investors in Hemax Genome, Inc.?
Current investors in Hemax Genome, Inc. include Emerillon Therapeutics, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Hemax Genome, Inc. been involved in?
Hemax Genome, Inc. has 1 transaction tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Hemax Genome, Inc. profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Hemax Genome, Inc.'s complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial